Company intelligence / Profile preview

Labrox

Turku, Southwest Finland, Finland

Ownership: Private
Employees: ~30
Development stage: Other

Overview

Labrox is a Finnish OEM manufacturer of microplate readers and point-of-care diagnostic instruments that supplies devices (often white‑label) to leading life‑science providers worldwide; it is not itself a therapeutic drug developer.[3][5][13]

Industry: Protein Biomarker Diagnostics

Partnerships

Kaivogen (co-development of Upcon point-of-care testing concept and Upcon reader)[3]Abacus Diagnostica (joint point-of-care diagnostics solution via combination into Uniogen)[3][6]Leading life-science providers as OEM customers (devices sold under their brands)[3][5]

Beyond the preview

Go deeper on Labrox.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Labrox.

Explore the full profile